Quarterly report pursuant to Section 13 or 15(d)

12. Segments

v3.8.0.1
12. Segments
6 Months Ended
Sep. 30, 2017
Segment Reporting [Abstract]  
Segments

We operate our businesses principally through two reportable segments: Aethlon, which represents our therapeutic business activities, and ESI, which represents our diagnostic business activities. Our reportable segments have been determined based on the nature of the potential products being developed. We record discrete financial information for ESI and our chief operating decision maker reviews ESI’s operating results in order to make decisions about resources to be allocated to the ESI segment and to assess its performance.

 

Aethlon’s revenue is generated primarily from government contracts to date and ESI does not yet have any revenues. We have not included any allocation of corporate overhead to the ESI segment.

 

The following tables set forth certain information regarding our segments:

 

    Six Months Ended September 30,  
    2017     2016  
Revenues:            
Aethlon   $     $ 392,073  
ESI            
Total Revenues   $     $ 392,073  
                 
Operating Losses:                
Aethlon   $ (2,373,066 )   $ (3,281,530 )
ESI     (23,356 )     (76,999 )
Total Operating Loss   $ (2,396,422 )   $ (3,358,529 )
                 
Net Losses:                
Aethlon   $ (3,130,772 )   $ (4,323,003 )
ESI     (23,356 )     (76,999 )
Net Loss Before Non-Controlling Interests   $ (3,154,128 )   $ (4,400,002 )
                 
Cash:                
Aethlon   $ 919,612     $ 553,884  
ESI     460       2,468  
Total Cash   $ 920,072     $ 556,352  
                 
Total Assets:                
Aethlon   $ 1,118,433     $ 914,179  
ESI     27,545       36,656  
Total Assets   $ 1,145,978     $ 950,835  
                 
Capital Expenditures:                
Aethlon   $ 23,705     $ 2,961  
ESI            
Capital Expenditures   $ 23,705     $ 2,961  
                 
Depreciation and Amortization:                
Aethlon   $ 18,651     $ 10,822  
ESI           9,790  
Total Depreciation and Amortization   $ 18,651     $ 20,612  
                 
Interest Expense:                
Aethlon   $ (250,583 )   $ (78,743 )
ESI            
Total Interest Expense   $ (250,583 )   $ (78,743 )